Skip to Content

FMX101 Approval Status

FDA Approved: No
Brand name: FMX101
Generic name: minocycline
Dosage form: Foam
Company: Foamix Pharmaceuticals
Treatment for: Acne

FMX101 (minocycline) is a topical foam formulation of minocycline in development for the treatment of moderate-to-severe acne vulgaris.

Development Status and FDA Approval Process for FMX101

DateArticle
Mar  7, 2019Foamix Announces FDA Acceptance of New Drug Application for FMX101 Minocycline Foam for the Treatment of Moderate-to-Severe Acne
Dec 21, 2018Foamix Submits New Drug Application to U.S. FDA Seeking Approval of FMX101 in Treatment of Moderate-to-Severe Acne
May  1, 2017Foamix Pharmaceuticals Announces Plans for Additional Phase 3 Trial for FMX101 in Moderate to Severe Acne

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide